POSTTRAUMATIC STRESS DISORDER
Clinical trials for POSTTRAUMATIC STRESS DISORDER explained in plain language.
Never miss a new study
Get alerted when new POSTTRAUMATIC STRESS DISORDER trials appear
Sign up with your email to follow new studies for POSTTRAUMATIC STRESS DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a video game rewire the brain to ease PTSD?
Symptom relief TerminatedThis pilot study tested a digital training task called GAMBIT in 50 adults with PTSD. The goal was to see if playing this brain-training game could improve brain circuit flexibility and reduce PTSD symptoms. The study was terminated early, so the findings are limited.
Matched conditions: POSTTRAUMATIC STRESS DISORDER
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Eye-Tracking training may ease PTSD in veterans
Symptom relief TerminatedThis study tested a new therapy that uses eye-tracking to help veterans with PTSD change how they look at threatening faces. The treatment, called Gaze-Contingent Music Reward Therapy, gives feedback based on where participants look, aiming to reduce stress. The trial included 12…
Matched conditions: POSTTRAUMATIC STRESS DISORDER
Phase: PHASE2, PHASE3 • Sponsor: Tel Aviv University • Aim: Symptom relief
Last updated Jun 26, 2026 15:13 UTC
-
Brain test may help match PTSD patients to the right antidepressant
Knowledge-focused TerminatedThis study aimed to see if a simple brain-wave test (LDAEP) could predict which veterans with PTSD or depression would improve with the SSRI medication sertraline (Zoloft). Participants took sertraline or a placebo for 14 weeks while researchers measured their brain activity and …
Matched conditions: POSTTRAUMATIC STRESS DISORDER
Phase: PHASE4 • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
PTSD drug safety study halted early: what we know
Knowledge-focused TerminatedThis small Phase 2 study aimed to test the safety and dosing of an intravenous drug called allopregnanolone (also known as brexanolone) in 11 people with chronic PTSD. The trial was terminated before completion, so results are limited. The main goal was to monitor sedation levels…
Matched conditions: POSTTRAUMATIC STRESS DISORDER
Phase: PHASE2 • Sponsor: Boston University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC